Although curcumin displays several beneficial properties, its medicinal use is limited by its low bioavailability. In the present study we report the antioxidant potentials of two bioconjugates of curcumin with nicotinic acid and picolinic acid: di-O-nicotinoyl curcumin [1,7-bis (4-Onicotinoyl-3-methoxyphenyl)-1,6-heptadiene-3, 5-dione] and di-O-picolinoyl curcumin [1,7-bis (4-O-picolinoyl-3-methoxyphenyl)-1,6heptadiene-3, 5-dione], in terms of ferric reducing, radical scavenging and β-carotene bleaching abilities, and comparing the observed activity with that of curcumin. Results demonstrate that both the bioconjugates possess higher antioxidant potentials as evidenced by enhanced ferric reducing, radical scavenging and β-carotene bleaching abilities, in comparison with curcumin. On the basis of our results we conclude that these bioconjugates of curcumin may be better than curcumin for medicinal and pharmacological applications.
Curcumin, 1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6heptadiene-3,5-dione is a natural yellow pigment isolated from turmeric (Curcuma longa). Curcumin is known to exhibit anticancer, anti-inflammatory, anti-diabetic, antiviral and neuroprotective properties [1, 2] . The compound is also reported to reduce blood cholesterol, enhance wound healing, protect from liver injuries and cataract formation [3, 4] . Although multiple mechanism(s) of action have been reported for curcumin, the antioxidant property associated with this molecule has been a subject of great attention and many of the associated biological and pharmacological effects attributed to it [4, 5] .
Pleiotropic health beneficial properties make curcumin an important pharmacologically active molecule, but low bioavailability, poor absorption and rapid metabolism in the liver and intestinal wall limits its use as a therapeutic agent [6, 7] . Its highly hydrophobic nature also reduces systemic administration, and it has been shown that on intravenous administration, curcumin disappears rapidly from the blood and quickly appears as metabolites in the bile [7, 8] . In order to overcome these limitations, curcumin may attach to ligands that can enhance its solubility, bioavailability, slowdown the metabolism and increase the rate of cellular uptake [9] . Keeping this rationale in mind, two bioconjugates of curcumin have been synthesized comprised of nicotinic acid (vitamin B3) and its isomer picolinic acid: di-O-nicotinoyl curcumin [1,7-bis (4-Onicotinoyl-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] (DNC) and di-O-picolinoyl curcumin [1,7- (DPC, Figure 1) ]. In the present study these bioconjugates have been screened for their antioxidant potential in terms of ferric reducing, radical scavenging and β-carotene bleaching activities in an effort to assess their efficacy as antioxidant moieties compared with the parent molecule i.e. curcumin.
Both the synthesized bioconjugates, DNC and DPC, showed enhanced ferric reducing ability in comparison with curcumin itself (p < 0.05), when assayed with FRAP reagent. The ability of DNC and DPC to reduce the ferric ion was 43% and 45% higher, respectively compared with curcumin ( Figure 2 ). Similar to the ferric reducing ability, both the bioconjugates of curcumin inhibited DPPH • at a higher rate than curcumin (p < 0.001). Interestingly, DPC NPC Natural Product Communications 2011 Vol. 6 No. 12 1877 -1880 showed a slightly higher radical scavenging ability/antiradical power than DNC. The ability of DNC and DPC to inhibit DPPH • was 42% and 51%, respectively higher than curcumin ( Figure 3 ). Both the bioconjugates showed strong β-carotene bleaching capacity when tested, in comparison with curcumin. DNC elicited 20% and DPC 23% more bleaching capacity than curcumin ( Figure 4 ).
The FRAP assay, based on ferric reducing ability of biological samples, is one of the most frequently used methods to evaluate antioxidant activity since it is independent of the enzymatic/non-enzymatic method to generate free radicals prior to evaluating the anti-radical activity of antioxidants. The ability to reduce the ferric ion at higher rates by both the bioconjugates of curcumin, confirms their higher antioxidant potentials compared with curcumin. The estimation of radical scavenging activity of curcumin along with its bioconjugates using the DPPH • method presented the advantage of using a stable and commercially available free radical. This method has been extensively applied to the study of antiradical power of biological compounds [10, 11] . Easy to perform and high reproducibility adds extra advantage over other methods. Inhibition of DPPH• by DNC and DPC at higher rates than curcumin supports the results obtained from the FRAP assay.
The β-carotene bleaching assay is a reproducible and authentic method to measure the antioxidant capacity of different biological samples. The enhanced capacity of the synthesized bioconjugates to bleach β-carotene in comparison with curcumin confirms their greater antioxidant potential.
The presence of the carboxyl side chain at the ortho position and intramolecular coordination of the carboxylic group and nitrogen of the pyridine nuclei facilitates the proton donating ability of DPC. This may be the reason for the slightly higher DPPH • scavenging and β carotene bleaching activity of DPC in comparison with DNC.
Chemically, curcumin is a bis-α,β-unsaturated β-diketone (commonly called diferuloylmethane, Figure1), which exhibits keto-enol tautomerism, having a predominant keto form in acidic and neutral solutions and a stable enol form in alkaline media. The double bonds in curcumin provide definite conformational flexibility to the molecule, which accounts for its various properties [12, 13] .
The inherent disadvantage with respect to curcumin is its poor solubility in aqueous systems, which makes its use in water-based food products difficult. The alkyl and aryl portions of this molecule render it lipophilic and thus restrict its uptake into cells [14, 15] . Antioxidant properties of a number of ring-substituted analogues of curcumin show that the highest antioxidant activity is obtained when the phenolic group is sterically hindered [15] . Therefore, one of the most practical approaches is to make biodegradable conjugates of curcumin with suitable ligands to enhance its cellular uptake [16] . The site of attachment of ligands to the curcumin molecule can be at phenolic hydroxyls, ketogroups (enol functions) or the active methylene group.
The masking of phenolic groups with ligands such as amino acids, nucleosides, and peptides has already been reported [7, 17, 18] . We are the first to select vitamin B3complex as a ligand. The bioconjugates: DNC and DPC prepared with nicotinic acid and its isomer picolinic acid Antioxidant potentials of two bioconjugates of curcumin Natural Product Communications Vol. 6 (12) 2011 1879 have a biodegradable ester linkage. Since both ligands used are natural and are essential components which play a vital role in cellular physiology, the bioconjugates synthesized are predicted to enhance cellular uptake and be more efficacious than pure curcumin.
The vitamin derivatives of curcumin showed higher ferric reducing, free radical scavenging and β-carotene bleaching activities than pure curcumin, thus demonstrating that derivatization at the phenolic position of curcumin improved in vitro antioxidant activity. Results of our study on screening of antioxidant potential of curcumin bioconjugates may be useful in developing more efficacious conjugates of curcumin with enhanced bioavailability incorporating better pharmacological and biological effects.
Experimental

Synthesis of di-O-nicotinoyl curcumin [1,7-bis (4-Onicotinoyl-3-methoxyphenyl)-1, 6-heptadiene-3, 5-dione:
Redistilled thionyl chloride (1.09 mL, 0.015 mol) was added to 1.23 g of nicotinic acid (0.01 mol) and refluxed for 30 min. The reaction mixture was evaporated to dryness on a rotary evaporator under reduced pressure.
[yield = 72% (0.890 g, 6 mmol)]. One hundred mg curcumin (0.27 mmol) in 5 mL dimethyl formamide (DMF) was mixed with nicotinic chloride (90 mg ≈ 0.6 mmol). A few drops of triethylamine were added as catalyst and the reaction mixture was stirred overnight at room temperature. The completion of reaction was checked by TLC. The reaction mixture was then poured into chilled water (10 mL), shaken well, and then extracted with DCM (dichloromethane) thrice (5 mL each time). Na 2 SO 4 (1g) was added to the extracted DCM, the solution kept overnight, then filtered, the filtrate evaporated to dryness, and then purified by silica gel CC using DCM/MeOH gradient. Yield: 42%. Rf: 0.81 (DCM/MeOH; 9.8: 0.2). UV λmax (MeOH): 260 (s), 290,320 (s) nm. 1 [1,7-bis (4-Opicolinoyl-3-methoxyphenyl)-1, 6-heptadiene-3 
Synthesis of di-O-picolinoyl curcumin
Ferric reducing antioxidant potential (FRAP) assay:
The antioxidant capacity of the bioconjugates and curcumin was determined by the ferric reducing antioxidant potential (FRAP) assay, following the method of Benzie and Strain [19] . Working FRAP reagent was prepared by mixing acetate buffer (300 mM, pH 3.6), 2, 4, 6-tri [2-pyridyl]-striazine (10 mM in 40 mM HCl) solution and FeCl 3 .6H 2 O (20 mmol/L) solution in 10:1:1 ratio, respectively. Three mL of FRAP reagent was mixed with 10 µM of each sample solution and the content mixed vigorously. The absorbance was read at 593 nm at intervals of 30 sec for 4 min. An aqueous solution of Fe 2+ in the range of 100 -1000 µmol/L was used for calibration. Using the regression equation, the FRAP values (µmol Fe (II)/L) of the compounds were calculated.
1,1-Diphenyl-2-picrylhydrazyl free radical (DPPH • ) assay:
Anti-radical activity of curcumin and both the bioconjugates was estimated by the procedure described by Miliauskas et al. [20] . Briefly, 0.1 mL of each compound was incubated in a methanolic solution of DPPH • (0.1 mM). Absorbance at 517 nm was measured after 30 min of incubation with vigorous shaking. Methanol was used as blank reference. All the measurements were performed in triplicate. The free radical DPPH • scavenging (i.e. reduction) activity was calculated from the equation: Activity [% of DPPH reduction] = [(A-Ax)/A] × 100%, where A -absorbance of DPPH • solution with methanol, Ax -absorbance of a DPPH • solution with assayed compounds. β-Carotene bleaching assay: β-Carotene bleaching capacity of the synthesized bioconjugates was determined according to the method of Burda and Oleszek [21] . Briefly, 1 mL of β-carotene (0.2 mg/mL) was dissolved in chloroform containing 0.02 mL linoleic acid and 0.02 mL Tween 20. The mixture was then dosed with 0.2 mL of compound solution (final concentration 10 µM). Fifty mL of distilled water, saturated for 15 min with oxygen, was added to the flask. The resulting mixture was shaken and kept for 2 h at 50°C. The absorbance of the samples was measured at 470 nm, immediately after their preparation (t = 0 min) and at the end of the experiment (t = 120 min). Antioxidant activity was calculated as percent inhibition of oxidation versus control, using the equation: % β-carotene bleaching = 100 [1-(As 0 -As t )/ (Ac 0 -Ac t )] where As 0 : absorbance of sample at 0 min, As t : absorbance of the sample at 120 min, Ac 0 : absorbance of control at 0 min and Ac t : absorbance of control at 120 min.
